rs41549716

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_002693.3(POLG):ā€‹c.2492A>Gā€‹(p.Tyr831Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00879 in 1,613,824 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0068 ( 12 hom., cov: 33)
Exomes š‘“: 0.0090 ( 93 hom. )

Consequence

POLG
NM_002693.3 missense

Scores

3
6
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts U:1B:15

Conservation

PhyloP100: 0.782
Variant links:
Genes affected
POLG (HGNC:9179): (DNA polymerase gamma, catalytic subunit) Mitochondrial DNA polymerase is heterotrimeric, consisting of a homodimer of accessory subunits plus a catalytic subunit. The protein encoded by this gene is the catalytic subunit of mitochondrial DNA polymerase. The encoded protein contains a polyglutamine tract near its N-terminus that may be polymorphic. Defects in this gene are a cause of progressive external ophthalmoplegia with mitochondrial DNA deletions 1 (PEOA1), sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO), Alpers-Huttenlocher syndrome (AHS), and mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE). Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.014398247).
BP6
Variant 15-89321842-T-C is Benign according to our data. Variant chr15-89321842-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 13509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-89321842-T-C is described in Lovd as [Benign]. Variant chr15-89321842-T-C is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAd4 at 12 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
POLGNM_002693.3 linkuse as main transcriptc.2492A>G p.Tyr831Cys missense_variant 16/23 ENST00000268124.11 NP_002684.1 P54098E5KNU5
POLGNM_001126131.2 linkuse as main transcriptc.2492A>G p.Tyr831Cys missense_variant 16/23 NP_001119603.1 P54098E5KNU5
POLGARFNM_001406557.1 linkuse as main transcriptc.*1764A>G 3_prime_UTR_variant 16/23

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
POLGENST00000268124.11 linkuse as main transcriptc.2492A>G p.Tyr831Cys missense_variant 16/231 NM_002693.3 ENSP00000268124.5 P54098

Frequencies

GnomAD3 genomes
AF:
0.00680
AC:
1034
AN:
152154
Hom.:
12
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00138
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00268
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.0161
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0110
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.00662
AC:
1664
AN:
251428
Hom.:
12
AF XY:
0.00649
AC XY:
882
AN XY:
135894
show subpopulations
Gnomad AFR exome
AF:
0.00166
Gnomad AMR exome
AF:
0.00176
Gnomad ASJ exome
AF:
0.000695
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00114
Gnomad FIN exome
AF:
0.0180
Gnomad NFE exome
AF:
0.00979
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00900
AC:
13155
AN:
1461552
Hom.:
93
Cov.:
32
AF XY:
0.00890
AC XY:
6469
AN XY:
727096
show subpopulations
Gnomad4 AFR exome
AF:
0.00140
Gnomad4 AMR exome
AF:
0.00186
Gnomad4 ASJ exome
AF:
0.000995
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00107
Gnomad4 FIN exome
AF:
0.0174
Gnomad4 NFE exome
AF:
0.0103
Gnomad4 OTH exome
AF:
0.00807
GnomAD4 genome
AF:
0.00679
AC:
1034
AN:
152272
Hom.:
12
Cov.:
33
AF XY:
0.00659
AC XY:
491
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.00137
Gnomad4 AMR
AF:
0.00268
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00145
Gnomad4 FIN
AF:
0.0161
Gnomad4 NFE
AF:
0.0110
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00867
Hom.:
9
Bravo
AF:
0.00507
TwinsUK
AF:
0.0138
AC:
51
ALSPAC
AF:
0.0104
AC:
40
ESP6500AA
AF:
0.00159
AC:
7
ESP6500EA
AF:
0.0110
AC:
95
ExAC
AF:
0.00628
AC:
762
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00872
EpiControl
AF:
0.00765

ClinVar

Significance: Benign/Likely benign
Submissions summary: Uncertain:1Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Benign, criteria provided, single submitterclinical testingGeneDxDec 06, 2018This variant is associated with the following publications: (PMID: 22995991, 27987238, 18546365, 22647225, 21880868, 20818383, 20981092, 17846414, 15534189, 28471437, 29190809) -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024POLG: BS1, BS2 -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 02, 2023- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsOct 28, 2014- -
not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Dec 23, 2014- -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 29, 2016- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 06, 2020- -
Progressive sclerosing poliodystrophy Benign:3
Benign, criteria provided, single submitterclinical testingWong Mito Lab, Molecular and Human Genetics, Baylor College of MedicineOct 01, 2018The NM_002693.2:c.2492A>G (NP_002684.1:p.Tyr831Cys) [GRCH38: NC_000015.10:g.89321842T>C] variant in POLG gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant has been reported in PMID:16929381 ; 16943369 . This variant meets the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 4A (Alpers type). BS2:Observation of the variant in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 4A (Alpers type). BP6:Reputable source(s) without shared data suggest the variant is benign. Based on the evidence criteria codes applied, the variant is suggested to be Benign. -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyOMIMSep 11, 2007- -
POLG-Related Spectrum Disorders Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 10, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenNov 24, 2021- -
POLG-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesDec 01, 2023This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.047
T
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.83
D;D
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.25
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.86
.;D
MetaRNN
Benign
0.014
T;T
MetaSVM
Uncertain
0.69
D
MutationAssessor
Benign
1.7
L;L
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-2.8
D;D
REVEL
Pathogenic
0.73
Sift
Benign
0.11
T;T
Sift4G
Benign
0.12
T;T
Polyphen
0.99
D;D
Vest4
0.70
MVP
0.94
MPC
0.72
ClinPred
0.033
T
GERP RS
1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.45
gMVP
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41549716; hg19: chr15-89865073; COSMIC: COSV99175162; COSMIC: COSV99175162; API